Efficacy of colchicine in patients with moderate COVID-19: A double-blinded, randomized, placebo-controlled trial

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may cause severe life-threatening diseases called acute respiratory distress syndrome (ARDS) owing to cytokine storms. The mortality rate of COVID-19-related ARDS is as high as 40% to 50%. However, effective treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Motlabur, Datta, Ponkaj K., Islam, Khairul, Haque, Mahfuzul, Mahmud, Reaz, Mallik, Uzzwal, Hasan, Pratyay, Haque, Manjurul, Faruq, Imtiaz, Sharif, Mohiuddin, Ratul, Rifat H., Azad, Khan Abul Kalam, Miah, Titu, Rahman, Md. Mujibur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668149/
https://www.ncbi.nlm.nih.gov/pubmed/36383611
http://dx.doi.org/10.1371/journal.pone.0277790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668149/
https://www.ncbi.nlm.nih.gov/pubmed/36383611
http://dx.doi.org/10.1371/journal.pone.0277790

Ejemplares similares